Similar articles

• Invasive meningococcal disease associated with a very high case fatality rate in the North-West of Poland.

  Skoczyńska A, Kadłubowski M, Knap J, Szulc M, Janusz-Jurczyk M, Hryniewicz W. Skoczyńska A, et al. FEMS Immunol Med Microbiol. 2006 Mar;46(2):230-5. doi: 10.1111/j.1574-695X.2005.00027.x. FEMS Immunol Med Microbiol. 2006. PMID: 16487304
• Invasive meningococcal disease in Canada, 1 January 1997 to 31 December 1998.

  Squires SG, Pelletier L, Mungai M, Tsang R, Collins F, Stoltz J. Squires SG, et al. Can Commun Dis Rep. 2000 Nov 1;26(21):177-82. Can Commun Dis Rep. 2000. PMID: 11107657 English, French. No abstract available.
• Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003.

  [No authors listed] [No authors listed] Can Commun Dis Rep. 2006 Apr 15;32(8):97-107. Can Commun Dis Rep. 2006. PMID: 16685767 English, French. No abstract available.
• Meningococcal vaccines: a neglected topic in travel medicine?

  Wilder-Smith A. Wilder-Smith A. Expert Rev Vaccines. 2009 Oct;8(10):1343-50. doi: 10.1586/erv.09.102. Expert Rev Vaccines. 2009. PMID: 19803757 Review.
• [Meningococcal diseases in Austria].

  Thiel W, Haas G, Heuberger S. Thiel W, et al. Wien Klin Wochenschr. 1998 Jun 26;110(12):415-22. Wien Klin Wochenschr. 1998. PMID: 9677660 Review. German. No abstract available.